 In evaluating the merits of a company, one promising indication of future success is to look at the pedigree of the companys leadership. This is where most over-the-counter stocks fail miserably, and this is also where success can beget further success for tenured executives who have proven their talents for creating value. One man, Patrick Soon-Shiong, has done just this and made himself the wealthiest American in the healthcare industry having amassed a fortune of 7.2 billion. Soon-Shiong invented the first FDA approved nanoparticle delivery technology for the treatment of breast cancer, Abraxane, which is now approved in over 40 countries. The company 